Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

NCT02090530 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT02090530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
November 4, 2013
Completion date
December 31, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer